macitentan

AssetSmall molecule

Dual endothelin receptor antagonist (ETA and ETB)

Stage: Phase 3
Modality: Small molecule
Target: EDNRA
Indications: 1
Trials: 1
Developers: 1

Indications

1

Pulmonary arterial hypertension
Phase 3ACTIVE_NOT_RECRUITINGNCT04273945clinicaltrials.gov7 Oct 2026

Targets and what it contains2
Owner and partners1
Trials1
Competitors1

Every asset’s record: target, stage, trials and the evidence behind it.

Updated 7 Oct 2026 · 1 source